Cargando…

Gadolinium should always be used to assess disease activity in MS – Yes

Detalles Bibliográficos
Autores principales:	Granziera, Cristina, Reich, Daniel S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Controversies in MS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293550/ https://www.ncbi.nlm.nih.gov/pubmed/32484018 http://dx.doi.org/10.1177/1352458520911174

Ejemplares similares

Slowly expanding lesions are a marker of progressive MS – No
por: Arnold, Douglas L, et al.
Publicado: (2021)

The multiple sclerosis prodrome is just unspecific symptoms in radiologically isolated syndrome patients – No
por: Tremlett, Helen, et al.
Publicado: (2021)

Low-dose rituximab should be used for treating MS in resource-limited settings: Yes
por: Piehl, Fredrik, et al.
Publicado: (2022)

Are Antibody Panels Under‐Utilized in Movement Disorders Diagnosis? Yes
por: Balint, Bettina
Publicado: (2021)

Much, if not all, of the cortical damage in MS can be attributed to the microglial cell – Yes
por: van Wageningen, Thecla A, et al.
Publicado: (2018)

Serum MOG IgG titres should be performed routinely in the diagnosis and follow-up of MOGAD: Yes
por: Reindl, Markus, et al.
Publicado: (2023)

Resistance to apoptosis should not be taken as a hallmark of cancer
por: Wang, Rui-An, et al.
Publicado: (2014)

MS can be considered a primary progressive disease in all cases, but some patients have superimposed relapses – Yes
por: Scalfari, Antonio
Publicado: (2021)

Stable multiple sclerosis patients on anti-CD20 therapy should go on extended interval dosing—“Yes”
por: Rolfes, Leoni, et al.
Publicado: (2021)

Presymptomatic MS or radiologically isolated syndrome (RIS) should be actively monitored and treated – NO
por: Smets, Ide
Publicado: (2023)

Quality of life should be the primary outcome for disease modifying therapy trials in MS—No
por: Strijbis, EMM, et al.
Publicado: (2023)

Low-dose rituximab should be used for treating MS in resource-limited settings: No
por: Mateen, Farrah J
Publicado: (2022)

Studying the blood–brain barrier will provide new insights into neurodegeneration – Yes
por: Kamphuis, Wouter W, et al.
Publicado: (2018)

4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes
por: Strijbis, Eva MM, et al.
Publicado: (2020)

Low Tidal Volume Should Not Routinely be Used for Emergency Department Patients Requiring Mechanical Ventilation
por: Wright, Brian J., et al.
Publicado: (2012)

All anti-CD20 monoclonal antibodies have similar efficacy and safety risks: Yes
por: Cree, Bruce AC
Publicado: (2022)

Controversies in the Interpretation of Liquid Biopsy Data in Lymphoma
por: Pirosa, Maria Cristina, et al.
Publicado: (2022)

Does Topical Tretinoin Used for Chemoprevention Cause Increased Mortality?
por: Sangolli, Prabhakar M
Publicado: (2009)

Changed definition of disease and broader screening criteria had little impact on prevalence of gestational diabetes mellitus
por: Grønvall, Lina, et al.
Publicado: (2021)

Lower is better in hypertension, but how low should blood pressure be targeted?
por: Touyz, Rhian M.
Publicado: (2016)

Should age matter in COVID-19 triage? A deliberative study
por: Kuylen, Margot N I, et al.
Publicado: (2021)

“I feel reassured, but there is no guarantee.” How do women with a future childbearing desire respond to active surveillance of cervical intraepithelial neoplasia grade 2? A qualitative study
por: Hansen, Joan, et al.
Publicado: (2022)

COVID-19 and schooling in South Africa: Who should go back to school first?
por: Spaull, Nic
Publicado: (2020)

New PET technologies – embracing progress and pushing the limits
por: Aide, Nicolas, et al.
Publicado: (2021)

Factors affecting MS patients’ health-related quality of life and measurement challenges in Lebanon and the MENA region
por: Farran, Natali, et al.
Publicado: (2020)

Controversies on the Consequences of Iron Overload and Chelation in MDS
por: Vinchi, Francesca, et al.
Publicado: (2020)

Controversies in the Treatment of Peripheral T-cell Lymphoma
por: Bachy, Emmanuel, et al.
Publicado: (2020)

Controversies in the Treatment of Follicular Lymphoma
por: Hübel, Kai, et al.
Publicado: (2020)

Controversy: Is There a Role for Adjuvants in the Management of Male Pattern Hair Loss?
por: Rajput, Rajendrasingh J
Publicado: (2010)

Minimally Invasive Vitreoretinal Surgery: Is Sutureless Vitrectomy the Future of Vitreoretinal Surgery?
Publicado: (2011)

Botulinum Toxin Deaths: What is the Fact?
por: Omprakash HM,, et al.
Publicado: (2008)

Stability in Vitiligo: Why Such a Hullabaloo?
por: Gupta, Somesh
Publicado: (2009)

Stability in Vitiligo? What's that?
por: Lahiri, Koushik
Publicado: (2009)

Radial Optic Neurotomy for Central Retinal Vein Occlusion
por: Ramezani, Ali-Reza
Publicado: (2009)

Controversies in the Treatment of Classical Hodgkin Lymphoma
por: Eichenauer, Dennis A., et al.
Publicado: (2018)

Does the Anti‐Tau Strategy in Progressive Supranuclear Palsy Need to Be Reconsidered? No
por: Höglinger, Günter U.
Publicado: (2021)

Endoscopic biliary drainage for malignant distal biliary obstruction: Which is better – endoscopic retrograde cholangiopancreatography or endoscopic ultrasound?
por: Bang, Ji Young, et al.
Publicado: (2021)

Term breech presentation—Intended cesarean section versus intended vaginal delivery—A systematic review and meta‐analysis
por: Wängberg Nordborg, Julia, et al.
Publicado: (2022)

Treatment of apical vaginal prolapse with minimal mesh repair (Uphold): patient‐reported long‐term outcomes and mesh‐related complications
por: Munch, Anne, et al.
Publicado: (2022)

Evidence of latent HPV infection in older Danish women with a previous history of cervical dysplasia
por: Hammer, Anne, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bqdr88d594rvgta0buq1jd0f71